BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology company can be. The company has evolved beyond ...

Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...

RICHMOND, Va. (WRIC) — Nadia Tasnim Ahmed, a student at Virginia Commonwealth University (VCU) in Richmond, will soon become the first person in America to have a Ph.D in pharmaceutical engineering.

Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing Purpose-built to optimise the ...

Professor Christopher Burcham was elected to the National Academy of Engineering for contributions to pharmaceutical engineering.

While 2025 has not been a banner year for biopharma dealmaking, antibodies that bind two or more molecular targets—so-called multispecifics—have taken center stage. The top three licensing deals and ...

Synthetic biology—an emerging and often debated field—involves the application of engineering principles to biological systems. While its definition has evolved over time, the European Commission ...

Pharmaplan fully integrated into Exyte, unifying biopharma engineering capabilities under one European organization. Integrated setup drives strong client demand and a record order-intake level in ...

Fabtech Technologies, a biopharma engineering solutions provider, has launched its IPO on September 29. The Rs 230 crore issue, entirely a fresh issue of 1.21 crore shares, will close on October 1.

Fabtech Technologies, a specialist in biopharma engineering solutions, launched its initial public offering (IPO) on Monday, September 29. Early bidding on the first day saw a modest overall ...